Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : TCR-T Cell Therapy
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Charles River Laboratories, Inc
Deal Size : Undisclosed
Deal Type : Agreement
Charles River, Captain T Cell Sign Plasmid DNA & Viral Vector Production Program Agreement
Details : Captain T Cell will have access to established plasmid and viral vector CDMO capabilities and advisory services ahead of its plan to manufacture a TCR-T cell therapy for solid tumor patients for a Phase I clinical trial.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
June 17, 2024
Lead Product(s) : TCR-T Cell Therapy
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Charles River Laboratories, Inc
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?